as mentioned in bbc
Pfizer and Medivation reportedly close to $14bn deal
Pfizer and Medivation reportedly close to $14bn deal
Image copyright Getty ImagesUS pharmaceutical giant Pfizer is reportedly in advanced talks to buy cancer drug company Medivation for about $14bn (£10.7bn).The Financial Times and Bloomberg were among news groups reporting that an announcement of a takeover could come early this week.San Francisco-based Medivation produces the prostate-cancer treatment Xtandi.France's Sanofi had tried to buy Medivation, and Merck & Co and Celgene were also said to have considered bids.
as well cityam
Viagra maker Pfizer is closing on a $14bn takeover of Xtandi maker Medivation
Viagra maker Pfizer is closing on a $14bn takeover of Xtandi maker Medivation
Oliver GillPfizer is closing in on a deal to buy cancer drug developer Medivation for nearly $14bn.The $80-a-share offer represents a 20 per cent premium to the San Francesco-based company's share price.Medivation put itself up for sale earlier this year following an offer made by French pharmaceutical-giant Sanofi for $52.50 a share.A second offer was made at $58 a share.
let alone ft
Pfizer nears $14bn takeover of Medivation
Pfizer nears $14bn takeover of Medivation
You have viewed your allowance of free articles.If you wish to view more, click the button below.
No comments:
Post a Comment